Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05710822

QDOT Based PVI for Atrial Fibrillation Treatment - The peQasus Study

Conditions: Atrial Fibrillation

Sex: All
Enrollment: 300
Sponsor: University of Luebeck

Summary

PeQasus is a worldwide, retrospective, multicenter analysis focusing on QDOT based PVI. Data of at least 300 patients with QDOT based PVI will be collected. All data will be evaluated after anonymization. Primary endoints are efficacy and safety.

Eligibility Criteria

Inclusion Criteria:Suitable for PVIExclusion Criteria:Non suitable for PVI

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05710822). StuddyBuddy aggregates publicly available trial information.